Nuclear phosphoproteomics analysis reveals that CDK1/2 are involved in EGF-regulated constitutive pre-mRNA splicing in MDA-MB-468 cells
- 1 June 2016
- journal article
- research article
- Published by Elsevier in Journal of Proteomics
- Vol. 141, 77-84
Abstract
No abstract availableKeywords
Funding Information
- National High Technology Research and Development Program of China (2012AA020206)
- National Basic Research Program of China (2009CB522204)
This publication has 35 references indexed in Scilit:
- EGFR and NF-κB: partners in cancerTrends in Molecular Medicine, 2015
- Epidermal growth factor receptor targeting in cancer: A review of trends and strategiesBiomaterials, 2013
- The emerging multiple roles of nuclear AktBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locationsCancer Letters, 2012
- Elk-1 a Transcription Factor with Multiple Facets in the BrainFrontiers in Neuroscience, 2011
- The Translocon Sec61β Localized in the Inner Nuclear Membrane Transports Membrane-embedded EGF Receptor to the NucleusJournal of Biological Chemistry, 2010
- Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survivalBritish Journal of Cancer, 2006
- EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalizationBreast Cancer Research and Treatment, 2005
- STATs in oncogenesisOncogene, 2000
- Functional nuclear epidermal growth factor receptors in human choriocarcinoma JEG-3 cells and normal human placenta.Endocrinology, 1995